Rechallenge of ipilimumab and nivolumab in advanced melanoma patients after previous ipilimumab-based therapy. van Dijk EJ, Nienhuis HH, van den Eertwegh AJM, Boers-Sonderen MJ, et al. Br J Cancer 2025 Apr 29. doi: 10.1038/s41416-025-03027.

Read + Share

Amedeo Smart

Independent Medical Education

van Dijk EJ, Nienhuis HH, van den Eertwegh AJM, Boers-Sonderen MJ, et al. Rechallenge of ipilimumab and nivolumab in advanced melanoma patients after previous ipilimumab-based therapy. Br J Cancer 2025 Apr 29. doi: 10.1038/s41416-025-03027.
PMID: 40295727